These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 24356800

  • 1. Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
    Debergh I, Van Damme N, De Naeyer D, Smeets P, Demetter P, Robert P, Carme S, Pattyn P, Ceelen W.
    Ann Surg Oncol; 2014 Jun; 21(6):2097-104. PubMed ID: 24356800
    [Abstract] [Full Text] [Related]

  • 2. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
    Chen WT, Shih TT, Chen RC, Tu SY, Hsieh WY, Yang PC.
    Mol Imaging; 2012 Jun; 11(4):286-300. PubMed ID: 22954145
    [Abstract] [Full Text] [Related]

  • 3. Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging?
    Kiessling F.
    Radiology; 2013 Aug; 268(2):309-11. PubMed ID: 23882090
    [Abstract] [Full Text] [Related]

  • 4. A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes.
    Liu Y, Yang Y, Zhang C.
    Int J Nanomedicine; 2013 Aug; 8():1083-93. PubMed ID: 23515638
    [Abstract] [Full Text] [Related]

  • 5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 6. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
    Liu Z, Jia B, Shi J, Jin X, Zhao H, Li F, Liu S, Wang F.
    Bioconjug Chem; 2010 Mar 17; 21(3):548-55. PubMed ID: 20184307
    [Abstract] [Full Text] [Related]

  • 7. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
    Yan F, Xu X, Chen Y, Deng Z, Liu H, Xu J, Zhou J, Tan G, Wu J, Zheng H.
    Ultrasound Med Biol; 2015 Oct 17; 41(10):2765-73. PubMed ID: 26166460
    [Abstract] [Full Text] [Related]

  • 8. Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis.
    Huo T, Du X, Zhang S, Liu X, Li X.
    Eur J Radiol; 2010 Feb 17; 73(2):420-7. PubMed ID: 19261416
    [Abstract] [Full Text] [Related]

  • 9. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
    Xue S, Zhang C, Yang Y, Zhang L, Cheng D, Zhang J, Shi H, Zhang Y.
    J Biomed Nanotechnol; 2015 Jun 17; 11(6):1027-37. PubMed ID: 26353592
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent.
    Kim YS, Zhou Y, Bryant H, Milenic DE, Baidoo KE, Lewis BK, Frank JA, Brechbiel MW.
    Bioorg Med Chem Lett; 2015 Jun 17; 25(10):2056-9. PubMed ID: 25870133
    [Abstract] [Full Text] [Related]

  • 11. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
    Chakravarty R, Chakraborty S, Dash A.
    Mini Rev Med Chem; 2015 Jun 17; 15(13):1073-94. PubMed ID: 26349490
    [Abstract] [Full Text] [Related]

  • 12. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
    Tan M, Burden-Gulley SM, Li W, Wu X, Lindner D, Brady-Kalnay SM, Gulani V, Lu ZR.
    Pharm Res; 2012 Apr 17; 29(4):953-60. PubMed ID: 22139536
    [Abstract] [Full Text] [Related]

  • 13. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P, Degrassi A, Calderan L, Farace P, Nicolato E, Crescimanno C, Sandri M, Giusti A, Pesenti E, Terron A, Sbarbati A, Osculati F.
    Clin Cancer Res; 2005 Aug 15; 11(16):5827-32. PubMed ID: 16115922
    [Abstract] [Full Text] [Related]

  • 14. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH, Kuo YT, Cheng TL, Chen CY, Chiu YY, Lai JJ, Chang CC, Jaw TS, Wang YM, Liu GC.
    Kaohsiung J Med Sci; 2013 May 15; 29(5):246-53. PubMed ID: 23639510
    [Abstract] [Full Text] [Related]

  • 15. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
    Zheng Y, Ji S, Tomaselli E, Yang Y, Liu S.
    Nucl Med Biol; 2015 Feb 15; 42(2):137-45. PubMed ID: 25459111
    [Abstract] [Full Text] [Related]

  • 16. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.
    Beer AJ, Grosu AL, Carlsen J, Kolk A, Sarbia M, Stangier I, Watzlowik P, Wester HJ, Haubner R, Schwaiger M.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6610-6. PubMed ID: 18006761
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.
    Ke T, Jeong EK, Wang X, Feng Y, Parker DL, Lu ZR.
    Int J Nanomedicine; 2007 Nov 15; 2(2):191-9. PubMed ID: 17722547
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH, Furukawa T, Galibert M, Boturyn D, Coll JL, Fukumura T, Saga T, Dumy P, Fujibayashi Y.
    Nucl Med Biol; 2011 May 15; 38(4):529-40. PubMed ID: 21531290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.